34 Therapeutic Targeting of the SLC7A11-GCLM-GPX4 Axis Sensitizes Glioblastoma to Ferroptosis and Associates with Poor Survival

Clicks: 26
ID: 326697
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #72 of 286 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Glioblastoma (GBM) is the most common malignant primary brain tumor with a dismal prognosis. The high proliferative activity of GBM is prone to generating oxidative stress, which must be counteracted to support cell survival and prevent ferroptotic cell death. Objective The present study evaluated the expression of the GPX-4 and GCLM involved in redox homeostasis in GBM and their possible implications for tumor biology, clinical outcome, and therapeutic potential. Methodology The mRNA and protein expression were assessed by qPCR and immunohistochemistry, respectively, in 85 GBMs. For comparison, astrocytomas, grade 4 (n = 19), grade 2/3 (IDH-mutant) (n = 15), and oligodendrogliomas, grade 2/3 (IDH-mutant) (n = 13), were also evaluated. Normal brain (n = 5) used as control. In vitro analysis was performed on the U87MG and LN229 glioma cell lines. MTT assay, migration/invasion assay, and flow-cytometric assay (for cell death) were performed. Results The expression of GPX-4 and GCLM was significantly higher in GBM than in normal brain and lower-grade gliomas at mRNA and protein levels. High GPX4 expression was associated with significantly higher MIB-1 labeling. Inhibition of GPX-4/GCLM in vitro by RSL-3, FIN-56, and BSO was associated with increased cell death, elevated lipid ROS and reduced invasion and migration. Strong expression of GPX-4 and GCLM was associated with shorter overall survival in gliomas and GBM together. The GPX4/GCLM axis, which balances redox, is highly expressed and crucial for GBM cell survival and aggressive biological behavior. Given its predominantly immunopositivity in neoplastic cells and strong positivity in GBM, it may be a valuable adjunct to diagnosis. The present study also emphasized the role of GPX-4/GCLM as a potential therapeutic target, as demonstrated by RSL3, FIN56, and BSO.
Reference Key
openalex_W7204445660 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Minakshi Behera, Suvendu Purkait, Amit Ghosh, Rabi Narayan Sahu, Sandip Kumar Barik
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.076
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.076/70805941/noag172.076.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.